Citation 105379

MASUHR,TH: HOLSCHER,U: HONOLD,E:. (1994). BENEFIT-RISK EVALUATION OF VENOPLANT RETARD, A PRODUCT STANDARDIZED ON AESCIN AND BASED ON THE EXTRACT OF HORSE CHESTNUT SEED, IN PATIENTS SUFFERING FROM CHRONIC VENOUS INSUFFICIENCY.. 8()

Citation Details

TitleBENEFIT-RISK EVALUATION OF VENOPLANT RETARD, A PRODUCT STANDARDIZED ON AESCIN AND BASED ON THE EXTRACT OF HORSE CHESTNUT SEED, IN PATIENTS SUFFERING FROM CHRONIC VENOUS INSUFFICIENCY.
AuthorsMASUHR,TH: HOLSCHER,U: HONOLD,E:
Year1994
Volume8
Issue

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Aesculus hippocastanum (HIPPOCASTANACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
VENOUS INSUFFICIENCY SYMPTOMATIC TREATMENT
None
ACTIVE
2
TOXIC EFFECT(GENERAL)
None
INACTIVE